Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 353-356

  Ornstein, David K ^a   Englert, Chad ^a   Gillespie, John W ^a   Paweletz, Cloud P ^b,c   Linehan, W Marston ^a   Emmert Buck, Michael R ^a   Petricoin III, Emanuel F ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER CELL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE TUMOR; PROTEIN EXPRESSION;

BLOTTING, WESTERN; DISSECTION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIUM; HUMANS; LASERS; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033975643     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., DeKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T., and Southwick, P. C. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283-1290, 1994.
2. Stenman, U. H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K., and Alfthan, O. A complex between prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222-226, 1991.
3. Lilja, H., Christensson, A., Dahlen, U., Matikainen, M. T., Nilsson, O., Pettersson, K., and Lovgren, T. Prostate-specific antigen in serum occurs predominately in complex with α1-anticymptrypsin. Clin. Chem., 37: 1618-1625, 1991.
4. Woodrum, D. L., Brawer, M. K, Partin, A. W., Catalona, W. J., and Southwick, P. C., Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J. Urol., 159: 5-12, 1998.
5. Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., Lange, P. H., Subong, E. N., Parson, R. E., Gasior, G. H., Loveland, K. G., and Southwick, P. C. Use of percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease. J. Am. Med. Assoc., 279: 1542-1547, 1998.
6. Chen, Z., Chen, H., and Stamey, T. A. Monoclonal antibodies 2F5 and 4G10 against prostate specific antigen (PSA) complexed to α1-antichymotrypsin. J. Urol., 160: 870-875, 1998.
7. Bjork, T., Bjartell, A., Abrahamsson, P. A., Hulkko, S., di Sant'Agnes, A., Lilja, H. α1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology, 43: 427-434, 1994.
8. Bjartell, A., Bjork, T., Matikainen, M. T., Abrahamsson, P., Santagnese, A., and Lilja, H. Production of α-1-antichymotrypsin by PSA-containing cells of human prostate epithelium. Urology, 42: 502-510, 1993.
9. Wu, G., Lilja, H., Cockett, A. T. K., and Gershagen, S. Cloning and characterization of the α-antichymotrypsin produced by human prostate tissue. Prostate, 34: 155-161, 1998.
10. Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chaqui, R. F., Zhunag, Z., Goldstien, S. R., Weiss, R. A., and Liota, L. A. Laser capture microdissection. Science (Washington DC), 274: 998-1001, 1996.
11. Bonner, R. F., Emmert-Buck, M. R., Cole, K., Pohida, T., Chuaqui, R., Goldstein, S., and Liotta, L. A. Laser capture microdissection: molecular analysis of tissue. Science (Washington DC), 278: 1481-1483, 1997.